跳至主要内容
临床试验/NCT07295093
NCT07295093已完成不适用

Association Between Age at Menopause and Levels of Anxiety and Depression

Ankara City Hospital Bilkent1 个研究点 分布在 1 个国家目标入组 136 人开始时间: 2024年12月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
136
试验地点
1
主要终点
Beck Anxıety Inventory (BAI), Anxiety level

研究概览

简要总结

Menopause is defined as the permanent cessation of menstrual cycles due to ovarian follicle depletion, typically occurring after age 50, and is associated with decreased estrogen levels. Primary ovarian insufficiency (POI) involves early ovarian dysfunction before age 40, with infertility as a key concern. Both menopause and POI may contribute to psychological symptoms, including anxiety and depression, influenced by sociodemographic and health factors. While literature reports anxiety in middle-aged women, data on its association with menopausal timing are limited. This study aims to compare women with POI and those undergoing natural menopause after age 40, assessing the relationship between age at menopause, anxiety, and depression, as well as the impact of fertility expectations on psychological well-being in POI patients.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
24 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Healthy women over 24 years of age who visited our hospital for routine outpatient check-ups, had been diagnosed with menopause, and had no history of psychiatric disorders before menopause.

排除标准

  • Cardiovascular diseases including hypertension
  • Type 1 or type 2 diabetes mellitus
  • Morbid obesity
  • Primary adrenal insufficiency
  • Uterine fibroids
  • Thyroid dysfunctions including Hashimoto thyroiditis and Grave's disease
  • Hepatic dysfunctions
  • Renal insufficiency
  • Genetic disorders in chromosome constitution or karyotype analysis including monosomy X, trisomy X and gene mutations as BMP15, FMR I, POFIB, and GDF9
  • Neurologic diseases
  • Psychiatric disorders
  • Autoimmune diseases or syndromes including Addison's disease, autoimmune syndromes, scleroderma, Sjogren's syndrome, myasthenia gravis, inflammatory bowel diseases, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus and familial Mediterranean fever
  • History of any malignancy
  • History of exposure to chemotherapeutic agents or radiotherapy
  • Individuals with a history of chronic or regular medication use that could cause anxiety or depression symptoms
  • Individuals with a personal history of psychiatric disorders
  • Individuals with a history of depression in the past 6 months.

结局指标

主要结局

Beck Anxıety Inventory (BAI), Anxiety level

时间窗: Baseline (single assessment at enrollment during routine clinic visit).

Anxiety severity measured by the Beck Anxiety Inventory (BAI) during routine clinic visit.

State-Trait Anxiety Scale (STAI) 1-2, Anxiety level

时间窗: Baseline (single assessment at enrollment during routine clinic visit).

Anxiety severity measured by the State-Trait Anxiety Inventory (STAI) forms 1 and 2 during routine clinic visit.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Merve Didem Eşkin Tanrıverdi

Medical Doctor

Ankara City Hospital Bilkent

研究点 (1)

Loading locations...

相似试验